Concepedia

Filipa Lynce

FL

50

Publications

4K

Citations

24

H-Index

2011

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Georgetown University

MedStar Georgetown University Hospital

Harvard University

Georgetown University Medical Center

Filipa Lynce is an author at Dana-Farber Cancer Institute specializing in medicine, breast cancer, and oncology.

ORCID

Top concepts

Publications per year

2011–2025

50

Publications

50

Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer

Aditya Bardia, Sara A. Hurvitz, Sara M. Tolaney et al. · New England Journal of Medicine · 2021 · 1.4K citations · Full text

Prevalence of Homologous Recombination–Related Gene Mutations Across Multiple Cancer Types

Arielle L. Heeke, Michael J. Pishvaian, Filipa Lynce et al. · JCO Precision Oncology · 2018 · 451 citations

Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer

Shaveta Vinayak, Sara M. Tolaney, Lee S. Schwartzberg et al. · JAMA Oncology · 2019 · 413 citations · Full text

Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer

Milan Radovich, Guanglong Jiang, Bradley A. Hancock et al. · JAMA Oncology · 2020 · 292 citations · Full text

Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline

Isabelle Bedrosian, Mark R. Somerfield, Maria Isabel Achatz et al. · Journal of Clinical Oncology · 2024 · 145 citations

Rows per page

1–5 of 50